127 related articles for article (PubMed ID: 2211709)
1. An immune complex selective affinity matrix utilizing a synthetic peptide.
Baumann MA; Anderson BE
J Biol Chem; 1990 Oct; 265(30):18414-22. PubMed ID: 2211709
[TBL] [Abstract][Full Text] [Related]
2. Mutual inhibition of the binding of Clq and protein A to rabbit IgG immune complexes.
Laky M; Sjöquist J; Moraru I; Gheţie V
Mol Immunol; 1985 Nov; 22(11):1297-302. PubMed ID: 3878459
[TBL] [Abstract][Full Text] [Related]
3. Arginine residues of the globular regions of human C1q involved in the interaction with immunoglobulin G.
Marqués G; Antón LC; Barrio E; Sánchez A; Ruiz S; Gavilanes F; Vivanco F
J Biol Chem; 1993 May; 268(14):10393-402. PubMed ID: 8486696
[TBL] [Abstract][Full Text] [Related]
4. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes.
Gorgani NN; Parish CR; Easterbrook Smith SB; Altin JG
Biochemistry; 1997 Jun; 36(22):6653-62. PubMed ID: 9184145
[TBL] [Abstract][Full Text] [Related]
5. Evidence that C1q binds specifically to CH2-like immunoglobulin gamma motifs present in the autoantigen calreticulin and interferes with complement activation.
Kovacs H; Campbell ID; Strong P; Johnson S; Ward FJ; Reid KB; Eggleton P
Biochemistry; 1998 Dec; 37(51):17865-74. PubMed ID: 9922153
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of a recombinant form of the C-terminal, globular head region of the B-chain of human serum complement protein, C1q.
Kishore U; Leigh LE; Eggleton P; Strong P; Perdikoulis MV; Willis AC; Reid KB
Biochem J; 1998 Jul; 333 ( Pt 1)(Pt 1):27-32. PubMed ID: 9639558
[TBL] [Abstract][Full Text] [Related]
7. Specific inhibition of the classical complement pathway by C1q-binding peptides.
Roos A; Nauta AJ; Broers D; Faber-Krol MC; Trouw LA; Drijfhout JW; Daha MR
J Immunol; 2001 Dec; 167(12):7052-9. PubMed ID: 11739526
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q column: ligand specific purification of immune complexes from human serum or plasma. Analysis of the interaction between C1q and immune complexes.
Kilgallon W; Amlot PL; Williams BD
Clin Exp Immunol; 1982 Jun; 48(3):705-14. PubMed ID: 6811171
[TBL] [Abstract][Full Text] [Related]
9. Synthetic peptides which inhibit the interaction between C1q and immunoglobulin and prolong xenograft survival.
Fryer JP; Leventhal JR; Pao W; Stadler C; Jones M; Walsh T; Zhong R; Zhang Z; Wang H; Goodman DJ; Kurek M; d'Apice AJ; Blondin B; Ivancic D; Buckingham F; Kaufman D; Abecassis M; Stuart F; Anderson BE
Transplantation; 2000 Sep; 70(5):828-36. PubMed ID: 11003366
[TBL] [Abstract][Full Text] [Related]
10. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
[TBL] [Abstract][Full Text] [Related]
11. An immune complex selective affinity column utilizing site-specific attachment of bovine conglutinin.
O'Donoghue GV; Okarma TB; Lee YM
Anal Biochem; 1993 Sep; 213(2):310-7. PubMed ID: 8238907
[TBL] [Abstract][Full Text] [Related]
12. Temperature-sensitive binding of solid phase C1q to aggregated human immunoglobulin G.
Gibbons JJ; Pohl DA; Tsai CC; Roodman ST
Biochim Biophys Acta; 1981 Sep; 670(2):146-9. PubMed ID: 6975125
[TBL] [Abstract][Full Text] [Related]
13. Modular organization of the carboxyl-terminal, globular head region of human C1q A, B, and C chains.
Kishore U; Gupta SK; Perdikoulis MV; Kojouharova MS; Urban BC; Reid KB
J Immunol; 2003 Jul; 171(2):812-20. PubMed ID: 12847249
[TBL] [Abstract][Full Text] [Related]
14. C1q is a nucleotide binding protein and is responsible for the ability of clusterin preparations to promote immune complex formation.
Roeth PJ; Easterbrook-Smith SB
Biochim Biophys Acta; 1996 Oct; 1297(2):159-66. PubMed ID: 8917617
[TBL] [Abstract][Full Text] [Related]
15. [Non-native conformational states of immunoglobulins: thermodynamic and functional analysis of rabbit IgG].
Vlasov AP; Kravchuk ZI; Martsev SP
Biokhimiia; 1996 Feb; 61(2):212-35. PubMed ID: 8717493
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q.
McCall MN; Easterbrook-Smith SB
Biochem J; 1989 Feb; 257(3):845-51. PubMed ID: 2784672
[TBL] [Abstract][Full Text] [Related]
17. [Determination of circulating immune complexes and of their component immunoglobulin classes M, G, and A with a C1q-ELISA].
Sequeira Peña GA; Herrmann D; Vogt KH; Jäger L
Allerg Immunol (Leipz); 1991; 37(1):37-45. PubMed ID: 2063729
[TBL] [Abstract][Full Text] [Related]
18. Localization of sites through which C-reactive protein binds and activates complement to residues 14-26 and 76-92 of the human C1q A chain.
Jiang H; Robey FA; Gewurz H
J Exp Med; 1992 May; 175(5):1373-9. PubMed ID: 1569403
[TBL] [Abstract][Full Text] [Related]
19. Quantitative analysis of the interaction between immune complex and C1q complement subcomponent. The role of interdomain interactions in rabbit IgG in binding of C1q to immune precipitates.
Vonderviszt F; Török J; Lakatos S; Kilár F; Závodszky P
Biochem J; 1987 Apr; 243(2):449-55. PubMed ID: 3498482
[TBL] [Abstract][Full Text] [Related]
20. Multisite association by recombinant proteins can enhance binding selectivity. Preferential removal of immune complexes from serum by immobilized truncated FB analogues of the B domain from staphylococcal protein A.
Huston JS; Cohen C; Maratea D; Fields F; Tai MS; Cabral-Denison N; Juffras R; Rueger DC; Ridge RJ; Oppermann H
Biophys J; 1992 Apr; 62(1):87-91. PubMed ID: 1600106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
